Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of Age
NCT05618249 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-12-15
Summary
This study would have as a starting point the results of a request carried out by the Medical Service Grand Est of the Health Insurance aiming to evaluate the number of boxes of PPI reimbursed in town pharmacy, in patients over 75 years old in the Grand Est of France from 01/01/2018 to 31/12/2018.
It aims to highlight and quantify a possible inappropriate use of PPIs in private practice.
Conditions
- Peptic Ulcer Disease
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-01
- Primary Completion
- 2020-06-30
- Completion
- 2020-08-30
Countries
- France
Study Locations
More Related Trials
-
Proton Pump Inhibitors (PPI): a Study to Improve Appropriate Prescriptions in the Elderly
NCT04637750 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control
NCT00713947 ·Status: WITHDRAWN ·Phase: PHASE4
-
Primary carE PPi dEprescRibing Trial
NCT05629143 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)
NCT01128127 ·Status: WITHDRAWN ·Phase: NA
-
Should I Continue Taking My Acid Reflux Medication? Development and Pilot Testing of a Patient Decision Aid
NCT02558049 ·Status: COMPLETED ·Phase: NA
-
Proton Pump Inhibitors and Risk of Community-acquired Pneumonia
NCT02555852 ·Status: COMPLETED
-
The Clinical Significance of Acid Rebound in Functional Dyspepsia
NCT01373970 ·Status: TERMINATED ·Phase: PHASE4
-
Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis
NCT01182597 ·Status: UNKNOWN ·Phase: PHASE3
-
Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor (PPI)
NCT01519375 ·Status: COMPLETED
-
High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding
NCT00374101 ·Status: COMPLETED ·Phase: PHASE3
-
Is Long-Term Proton Pump Inhibitor Use a Cause of Leaky Gut Syndrome
NCT06268834 ·Status: COMPLETED ·Phase: NA
-
Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding Ulcers
NCT00573924 ·Status: COMPLETED ·Phase: NA
-
Symptom Evaluation After Cessation of a Proton Pump Inhibitor in Healthy Volunteers
NCT00915239 ·Status: COMPLETED ·Phase: NA
-
Patterns of Antiacids Use in Patients With IHD Admitted to Department of Internal Medicine
NCT00392964 ·Status: COMPLETED
-
Smartphone App-assisted PPI
NCT06094062 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program
NCT03719170 ·Status: COMPLETED ·Phase: NA
-
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
NCT00037570 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
NCT03163680 ·Status: COMPLETED
-
Oral vs Intravenous and Proton Pump Inhibitor (PPI)for Peptic Ulcer Bleeding (PUB)
NCT01123031 ·Status: WITHDRAWN ·Phase: PHASE4
-
To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use
NCT01306799 ·Status: COMPLETED
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
NCT05976165 ·Status: RECRUITING ·Phase: NA
-
High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment
NCT00709046 ·Status: UNKNOWN ·Phase: NA
-
Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)
NCT00251732 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding
NCT03814421 ·Status: UNKNOWN ·Phase: NA
-
Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice
NCT00363701 ·Status: UNKNOWN ·Phase: PHASE4